Mission and Demographics
The mission of the International Tuberculosis Center (ITC) is to conduct research
and promote educational initiatives to combat the spread of tuberculosis (TB)
in Alabama and globally.
Center Research
In addition to the Center's primary mission to provide assistance in the design,
implementation and evaluation of innovative programs to combat TB, it also maintains
a strong commitment to TB education and training. Through the Gorgas Tuberculosis
Initiative, the ITC emphasizes training, education, and operations research
utilizing staff expertise in both medicine and public health to improve program
performance in countries with a high disease burden (such as Zambia, Honduras,
Peru, Kazakhstan, Indonesia, and Cambodia). These projects involve a spectrum
of foreign stakeholders, including academia and non-governmental organizations,
and wide range of research activities on a number of subjects such as multi-drug
resistant TB, TB-HIV co-infection, TB screening of HIV-infected patients, TB
control in prisons, and public-private mix. These activities are funded with
support from the United States Agency for International Development (USAID),
PEPFAR and the UAB Center for AIDS Research.
Domestically, ITC staff
is working in tandem with the Alabama Department of Public Health and the CDC
to conduct epidemiological research focused on foreign-born TB in Alabama. Past
research has focused on TB among the homeless, the molecular epidemiology of
transmission, enhancing the effectiveness of contact investigation, and the
issue of preventable childhood TB, resulting in publications in peer-reviewed
journals and elsewhere.
Capacity Development
In addition to providing technical assistance to specific field projects, the
ITC, primarily through the Gorgas Tuberculosis Initiative, works to develop
human resources for international TB control. This is done by: 1) providing
training to health professionals from the Former Soviet Union (FSU) and other
developing countries through the Sparkman International Public Health Summer
Institute at UAB, to fellows (UAB, Muskie, Fulbright, Fogarty), and to UAB graduate
students and staff; 2) participating in the Centers for Disease Control/World
Health Organization (CDC-WHO) Training Collaborative for the FSU; 3) sponsoring
workshops and symposia at international conferences; and 4) developing, translating,
printing, and disseminating TB training materials in manual and CD-Rom formats.
Dr. Kimerling and his staff also provide lectures on TB in the Schools of Medicine
and Public Health and are responsible for the TB Primer, last updated in April
2004. Distributed to all UAB medical house staff, the Primer is a product of
UAB's previous NIH-funded TB Academic Award. As the UAB Principal Investigator,
Dr. Kimerling is a member of the CDC-funded Tuberculosis Epidemiologic Studies
Consortium, which is a national network focused on operations research. He also
maintains close working ties with the WHO and the Stop TB Partnership, both
based in Geneva, as well as the International Union Against Tuberculosis and
Lung Disease, Paris.
For additional information:
Director: Michael E. Kimerling,
MD, MPH
Email: kimerlin@uab.edu
Phone: 205-934-1731
Administrator: Mayra Arias
Email: arias@uab.edu
Phone: 205-934-1731
Gorgas TB Initiative website:
www.gorgasinfo.org
Approved by: Michael E.
Kimerling, MD, MPH, Director
Date: May 14, 2007
Click here to return to the
SOM Research Web Site's home page.